<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36698809</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Luteolin-rich fraction from <i>Perilla frutescens</i> seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation <i>via</i> regulation of JAK1/STAT3 pathway: A potential anti-inflammatory compound against inflammation-induced long-COVID.</ArticleTitle><Pagination><StartPage>1072056</StartPage><MedlinePgn>1072056</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1072056</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.1072056</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The multi-systemic inflammation as a result of COVID-19 can persevere long after the initial symptoms of the illness have subsided. These effects are referred to as Long-COVID. Our research focused on the contribution of the Spike protein S1 subunit of SARS-CoV-2 (Spike S1) on the lung inflammation mediated by NLRP3 inflammasome machinery and the cytokine releases, interleukin 6 (IL-6), IL-1beta, and IL-18, in lung epithelial cells. This study has attempted to identify the naturally- occurring agents that act against inflammation-related long-COVID. The seed meal of <i>Perilla frutescens</i> (<i>P. frutescens</i>), which contains two major dietary polyphenols (rosmarinic acid and luteolin), has been reported to exhibit anti-inflammation activities. Therefore, we have established the ethyl acetate fraction of <i>P. frutescens</i> seed meal (PFEA) and determined its anti-inflammatory effects on Spike S1 exposure in A549 lung cells.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">PFEA was established using solvent-partitioned extraction. Rosmarinic acid (Ra) and luteolin (Lu) in PFEA were identified using the HPLC technique. The inhibitory effects of PFEA and its active compounds against Spike S1-induced inflammatory response in A549 cells were determined by RT-PCR and ELISA. The mechanistic study of anti-inflammatory properties of PFEA and Lu were determined using western blot technique.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">PFEA was found to contain Ra (388.70 &#xb1; 11.12 mg/g extract) and Lu (248.82 &#xb1; 12.34 mg/g extract) as its major polyphenols. Accordingly, A549 lung cells were pre-treated with PFEA (12.5-100 &#x3bc;g/mL) and its two major compounds (2.5-20 &#x3bc;g/mL) prior to the Spike S1 exposure at 100 ng/mL. PFEA dose-dependently exhibited anti-inflammatory properties upon Spike S1-exposed A549 cells through <i>IL-6</i>, IL-1&#x3b2;, <i>IL-18</i>, and <i>NLRP3</i> gene suppressions, as well as IL-6, IL-1&#x3b2;, and IL-18 cytokine releases with statistical significance (<i>p</i> &lt; 0.05). Importantly, Lu possesses superior anti-inflammatory properties when compared with Ra (<i>p</i> &lt; 0.01). Mechanistically, PFEA and Lu effectively attenuated a Spike S1-induced inflammatory response through downregulation of the JAK1/STAT3-inflammasome-dependent inflammatory pathway as evidenced by the downregulation of NLRP3, ASC, and cleaved-caspase-1 of the NLRP3 inflammasome components and by modulating the phosphorylation of JAK1 and STAT3 proteins (<i>p</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings suggested that luteolin and PFEA can modulate the signaling cascades that regulate Spike S1-induced lung inflammation during the incidence of Long-COVID. Consequently, luteolin and <i>P. frutescens</i> may be introduced as potential candidates in the preventive therapeutic strategy for inflammation-related post-acute sequelae of COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Dissook, Umsumarng, Mapoung, Semmarath, Arjsri, Srisawad and Dejkriengkraikul.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dissook</LastName><ForeName>Sivamoke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umsumarng</LastName><ForeName>Sonthaya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Veterinary Preclinical Sciences, Department of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mapoung</LastName><ForeName>Sariya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semmarath</LastName><ForeName>Warathit</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Akkraratchkumari Veterinary College, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arjsri</LastName><ForeName>Punnida</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srisawad</LastName><ForeName>Kamonwan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dejkriengkraikul</LastName><ForeName>Pornngarm</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">JAK1/STAT3 pathway</Keyword><Keyword MajorTopicYN="N">NLRP3 inflammasome pathway</Keyword><Keyword MajorTopicYN="N">Perilla frutescens extract</Keyword><Keyword MajorTopicYN="N">anti-inflammation</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">lung inflammation</Keyword><Keyword MajorTopicYN="N">luteolin (Lu)</Keyword><Keyword MajorTopicYN="N">spike glycoprotein S1</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>2</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36698809</ArticleId><ArticleId IdType="pmc">PMC9870545</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.1072056</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization [WHO]. COVID-19 Weekly Epidemiological Update, Edition 110, 21 September 2022. Geneva: WHO; (2022).</Citation></Reference><Reference><Citation>Dennis A, Wamil M, Kapur S, Alberts J, Badley A, Decker G, et al. Multi-organ impairment in low-risk individuals with long COVID. medRxiv. [Peprint]. (2020). 10.1101/2020.10.14.20212555</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.14.20212555</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. (2022) 32:e2315. 10.1002/rmv.2315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues T, de S&#xe1; K, Ishimoto A, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to sars-Cov-2 infection and are associated with COVID-19 severity in patients. J Exp Med. (2021) 218:e20201707. 10.1084/jem.20201707</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Wu S, Hu S, Li H, Li M, Geng X, et al. Nlrp3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin. Mol Med Rep. (2019) 20:1826&#x2013;36. 10.3892/mmr.2019.10382</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10382</ArticleId><ArticleId IdType="pmc">PMC6625427</ArticleId><ArticleId IdType="pubmed">31257469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu G, Shin H. Sars-Cov-2 infection of airway epithelial cells. Immune Netw. (2021) 21:e3. 10.4110/in.2021.21.e3</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2021.21.e3</ArticleId><ArticleId IdType="pmc">PMC7937510</ArticleId><ArticleId IdType="pubmed">33728096</ArticleId></ArticleIdList></Reference><Reference><Citation>Group P. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. (2022) 10:761&#x2013;75. 10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin S, Aktar S, Rahman M, Chowdhury M. Nlrp3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infec. (2022) 24:104913. 10.1016/j.micinf.2021.104913</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2021.104913</ArticleId><ArticleId IdType="pmc">PMC8613976</ArticleId><ArticleId IdType="pubmed">34838941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen I, Moriyama M, Chang M, Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the Nlrp3 inflammasome. Front Microbiol. (2019) 10:50. 10.3389/fmicb.2019.00050</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00050</ArticleId><ArticleId IdType="pmc">PMC6361828</ArticleId><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschopp J, Schroder K. Nlrp3 inflammasome activation: the convergence of multiple signalling pathways on ros production? Nat Rev Immunol. (2010) 10:210&#x2013;5. 10.1038/nri2725</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2725</ArticleId><ArticleId IdType="pubmed">20168318</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder K, Tschopp J. The inflammasomes. Cell. (2010) 140:821&#x2013;32. 10.1016/j.cell.2010.01.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.040</ArticleId><ArticleId IdType="pubmed">20303873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. Sars-Cov-2 cell entry depends on Ace2 and Tmprss2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosch S, Mahajan S, Collins A. Sars coronavirus spike protein-induced innate immune response occurs via activation of the Nf-Kappab pathway in human monocyte macrophages in vitro. Virus Res. (2009) 142:19&#x2013;27. 10.1016/j.virusres.2009.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2009.01.005</ArticleId><ArticleId IdType="pmc">PMC2699111</ArticleId><ArticleId IdType="pubmed">19185596</ArticleId></ArticleIdList></Reference><Reference><Citation>Holms R. Long COVID (PASC) is maintained by a self-sustaining pro-inflammatory TLR4/RAGE-loop of S100a8/A9&gt; TLR4/Rage signalling, inducing chronic expression of Il-1b, Il-6 and Tnfa: anti-inflammatory ezrin peptides as potential therapy. Immuno. (2022) 2:512&#x2013;33.</Citation></Reference><Reference><Citation>Pereira A, de Oliveira Andrade A, de Andrade Palis A, Cabral A, Barreto C, de Souza D, et al. Non-pharmacological treatments for COVID-19: current status and consensus. Res Biomed Eng. (2021) 38:193&#x2013;208.</Citation></Reference><Reference><Citation>Liskova A, Samec M, Koklesova L, Samuel S, Zhai K, Al-Ishaq R, et al. Flavonoids against the sars-Cov-2 induced inflammatory storm. Biomed Pharmacother. (2021) 138:111430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906511</ArticleId><ArticleId IdType="pubmed">33662680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathai R, Jindal M, Mitra J, Sar S. COVID-19 and medicinal plants: a critical perspective. Forensic Sci Int Anim Environ. (2022) 2:100043. 10.1016/j.fsiae.2022.100049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsiae.2022.100049</ArticleId><ArticleId IdType="pmc">PMC8837494</ArticleId><ArticleId IdType="pubmed">35187518</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Zhang Z, Hou T, Li X, Chen T. Optimization of ultrasound-assisted hexane extraction of perilla oil using response surface methodology. Ind Crops Prod. (2015) 76:18&#x2013;24.</Citation></Reference><Reference><Citation>Dhyani A, Chopra R, Garg MA. Review on nutritional value, functional properties and pharmacological application of perilla (Perilla frutescens L.). Biomed Pharmacol. (2019) 12:649&#x2013;60.</Citation></Reference><Reference><Citation>Zhou X, Yan L, Yin P, Shi L, Zhang J, Liu Y, et al. Structural characterisation and antioxidant activity evaluation of phenolic compounds from cold-pressed perilla frutescens var. arguta seed flour. Food Chem. (2014) 164:150&#x2013;7. 10.1016/j.foodchem.2014.05.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2014.05.062</ArticleId><ArticleId IdType="pubmed">24996318</ArticleId></ArticleIdList></Reference><Reference><Citation>Makino T, Furuta Y, Wakushima H, Fujii H, Saito K, Kano Y. Anti-allergic effect of perilla frutescens and its active constituents. Phytother Res. (2003) 17:240&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12672153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JH, Steigel A, Reininger E, Bauer R. Two new prenylated 3-benzoxepin derivatives as cyclooxygenase inhibitors from perilla frutescens var. acuta. J Nat Prod. (2000) 63:403&#x2013;5. 10.1021/np990362o</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/np990362o</ArticleId><ArticleId IdType="pubmed">10757731</ArticleId></ArticleIdList></Reference><Reference><Citation>Phromnoi K, Suttajit M, Saenjum C, Limtrakul Dejkriengkraikul P. Inhibitory effect of a rosmarinic acid-enriched fraction prepared from nga-mon (perilla frutescens) seed meal on osteoclastogenesis through the rank signaling pathway. Antioxidants. (2021) 10:307. 10.3390/antiox10020307</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10020307</ArticleId><ArticleId IdType="pmc">PMC7923133</ArticleId><ArticleId IdType="pubmed">33671207</ArticleId></ArticleIdList></Reference><Reference><Citation>Phromnoi K, Yodkeeree S, Pintha K, Mapoung S, Suttajit M, Saenjum C, et al. Anti-osteoporosis effect of perilla frutescens leaf hexane fraction through regulating osteoclast and osteoblast differentiation. Molecules. (2022) 27:824. 10.3390/molecules27030824</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27030824</ArticleId><ArticleId IdType="pmc">PMC8840259</ArticleId><ArticleId IdType="pubmed">35164085</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Zou L, Sun H, Peng J, Gao C, Bao L, et al. A review of the anti-inflammatory effects of rosmarinic acid on inflammatory diseases. Front Pharmacol. (2020) 11:153. 10.3389/fphar.2020.00153</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00153</ArticleId><ArticleId IdType="pmc">PMC7059186</ArticleId><ArticleId IdType="pubmed">32184728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda H, Yamazaki C, Yamazaki M. Luteolin as an anti-inflammatory and anti-allergic constituent of perilla frutescens. Biol Pharm Bull. (2002) 25:1197&#x2013;202. 10.1248/bpb.25.1197</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.25.1197</ArticleId><ArticleId IdType="pubmed">12230117</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapoung S, Umsumarng S, Semmarath W, Arjsri P, Srisawad K, Thippraphan P, et al. photoprotective effects of a hyperoside-enriched fraction prepared from houttuynia cordata thunb. on ultraviolet B-induced skin aging in human fibroblasts through the mapk signaling pathway. Plants. (2021) 10:12628. 10.3390/plants10122628</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/plants10122628</ArticleId><ArticleId IdType="pmc">PMC8708340</ArticleId><ArticleId IdType="pubmed">34961096</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmarath W, Mapoung S, Umsumarng S, Arjsri P, Srisawad K, Thippraphan P, et al. Cyanidin-3-O-glucoside and peonidin-3-O-glucoside-rich fraction of black rice germ and bran suppresses inflammatory responses from sars-Cov-2 spike glycoprotein S1-induction in vitro in a549 lung cells and THP-1 macrophages via inhibition of the Nlrp3 inflammasome pathway. Nutrients. (2022) 14:2738. 10.3390/nu14132738</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14132738</ArticleId><ArticleId IdType="pmc">PMC9268823</ArticleId><ArticleId IdType="pubmed">35807916</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M, Woo H. The paradigm of immune escape by sars-Cov-2 variants and strategies for repositioning subverted mabs against escaped vocs. Mol Ther. (2022) 30:3101&#x2013;5. 10.1016/j.ymthe.2022.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.08.020</ArticleId><ArticleId IdType="pmc">PMC9462941</ArticleId><ArticleId IdType="pubmed">36087577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zhi H, Teng Y. The outbreak of sars-Cov-2 omicron lineages, immune escape and vaccine effectivity. J Med Virol. (2022). [Epub ahead of print]. 10.1002/jmv.28138</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28138</ArticleId><ArticleId IdType="pmc">PMC9538491</ArticleId><ArticleId IdType="pubmed">36097349</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A, Kathuria A, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, et al. Post-COVID syndrome, inflammation, and diabetes. J Diabetes Complicat. (2022) 36:108336. 10.1016/j.jdiacomp.2022.108336</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108336</ArticleId><ArticleId IdType="pmc">PMC9534783</ArticleId><ArticleId IdType="pubmed">36228563</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of sars-Cov-2 by full-length human Ace2. Science. (2020) 367:1444&#x2013;8. 10.1126/science.abb2762</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Barilli A, Visigalli R, Ferrari F, Bianchi M, Dall&#x2019;Asta V, Rotoli B. Immune-mediated inflammatory responses of alveolar epithelial cells: implications for COVID-19 lung pathology. Biomedicines. (2022) 10:618. 10.3390/biomedicines10030618</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030618</ArticleId><ArticleId IdType="pmc">PMC8945544</ArticleId><ArticleId IdType="pubmed">35327420</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Shafiei M, Longoria C, Schoggins J, Savani R, Zaki H. Sars-Cov-2 spike protein induces inflammation via Tlr2-dependent activation of the Nf-kappab pathway. eLife. (2021) 10:e68563. 10.7554/eLife.68563</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjsri P, Srisawad K, Mapoung S, Semmarath W, Thippraphan P, Umsumarng S, et al. Hesperetin from root extract of clerodendrum petasites S. moore inhibits sars-Cov-2 spike protein S1 subunit-induced Nlrp3 inflammasome in A549 lung cells via modulation of the Akt/Mapk/Ap-1 pathway. Int J Mol Sci. (2022) 23:10346. 10.3390/ijms231810346</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810346</ArticleId><ArticleId IdType="pmc">PMC9498987</ArticleId><ArticleId IdType="pubmed">36142258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Lou F, Fan J, Li M, Tong Y. The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era. Lancet Microbe. (2022) 3:e91. 10.1016/S2666-5247(21)00278-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00278-0</ArticleId><ArticleId IdType="pmc">PMC8616564</ArticleId><ArticleId IdType="pubmed">34849495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Shin E. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. (2020) 20:585&#x2013;6. 10.1038/s41577-020-00429-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC8824445</ArticleId><ArticleId IdType="pubmed">32788708</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyer A, Gunther T, Robitaille A, Lutgehetmann M, Addo M, Jarczak D, et al. Remdesivir-induced emergence of sars-Cov2 variants in patients with prolonged infection. Cell Rep Med. (2022) 3:100735. 10.1016/j.xcrm.2022.100735</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100735</ArticleId><ArticleId IdType="pmc">PMC9378267</ArticleId><ArticleId IdType="pubmed">36075217</ArticleId></ArticleIdList></Reference><Reference><Citation>Byington C, Spencer L, Johnson T, Pavia A, Allen D, Mason E, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. (2002) 34:434&#x2013;40. 10.1086/338460</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338460</ArticleId><ArticleId IdType="pubmed">11797168</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi R, Javanmardi F, Mokhtari A, Hosseinpour P, Shahriarirad R, Ebrahimi K. Management of pleural empyema in a 12-year-old obese patient with COVID-19: a pediatric case report. BMC pediatr. (2021) 21:531. 10.1186/s12887-021-03007-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-03007-1</ArticleId><ArticleId IdType="pmc">PMC8630417</ArticleId><ArticleId IdType="pubmed">34847919</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenke K, Krawiec M, Kraj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community-acquired pneumonia. Clin Respir J. (2018) 12:253&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27401931</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H, Min D, Park H, Kim H. Flavonoids interfere with Nlrp3 inflammasome activation. Toxicol Appl Pharmacol. (2018) 355:93&#x2013;102. 10.1016/j.taap.2018.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2018.06.022</ArticleId><ArticleId IdType="pubmed">29960001</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo M, Moccia S, Spagnuolo C, Tedesco I, Russo G. Roles of flavonoids against coronavirus infection. Chem Biol Interact. (2020) 328:109211. 10.1016/j.cbi.2020.109211</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2020.109211</ArticleId><ArticleId IdType="pmc">PMC7385538</ArticleId><ArticleId IdType="pubmed">32735799</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Shin Y, Choi S, Oh S, Kim K, Jeong H, et al. Extracts of perilla frutescens var. Acuta (odash.) kudo leaves have antitumor effects on breast cancer cells by suppressing yap activity. Evid Based Complement Alternat Med. (2021) 2021:5619761. 10.1155/2021/5619761</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5619761</ArticleId><ArticleId IdType="pmc">PMC7899781</ArticleId><ArticleId IdType="pubmed">33628300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Liceaga A, Yoon K. Purification and identification of an antioxidant peptide from perilla seed (Perilla frutescens) meal protein hydrolysate. Food Sci Nutr. (2019) 7:1645&#x2013;55. 10.1002/fsn3.998</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.998</ArticleId><ArticleId IdType="pmc">PMC6526660</ArticleId><ArticleId IdType="pubmed">31139377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadeem M, Imran M, Aslam Gondal T, Imran A, Shahbaz M, Muhammad Amir R, et al. Therapeutic potential of rosmarinic acid: a comprehensive review. Appl Sci. (2019) 9:3139.</Citation></Reference><Reference><Citation>Rocha J, Eduardo-Figueira M, Barateiro A, Fernandes A, Brites D, Bronze R, et al. Anti-inflammatory effect of rosmarinic acid and an extract of rosmarinus officinalis in rat models of local and systemic inflammation. Basic Clin Pharmacol Toxicol. (2015) 116:398&#x2013;413. 10.1111/bcpt.12335</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.12335</ArticleId><ArticleId IdType="pubmed">25287116</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz N, Kim M, Cho J. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. (2018) 225:342&#x2013;58. 10.1016/j.jep.2018.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2018.05.019</ArticleId><ArticleId IdType="pubmed">29801717</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Lee W, Yun J. Luteolin inhibits hyperglycemia-induced proinflammatory cytokine production and its epigenetic mechanism in human monocytes. Phytother Res. (2014) 28:1383&#x2013;91. 10.1002/ptr.5141</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.5141</ArticleId><ArticleId IdType="pubmed">24623679</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes C, Almeida L, Barbosa R, Laranjinha J. Luteolin suppresses the Jak/Stat pathway in a cellular model of intestinal inflammation. Food Funct. (2017) 8:387&#x2013;96. 10.1039/c6fo01529h</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6fo01529h</ArticleId><ArticleId IdType="pubmed">28067377</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva G, Costa R, Silveira T, Caetano B, Horta C, Gutierrez F, et al. Apoptosis-associated speck-like protein containing a caspase recruitment domain inflammasomes mediate Il-1beta response and host resistance to trypanosoma cruzi infection. J Immunol. (2013) 191:3373&#x2013;83. 10.4049/jimmunol.1203293</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203293</ArticleId><ArticleId IdType="pubmed">23966627</ArticleId></ArticleIdList></Reference><Reference><Citation>Groslambert M, Py B. Spotlight on the Nlrp3 inflammasome pathway. J Inflamm Res. (2018) 11:359&#x2013;74. 10.2147/JIR.S141220</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S141220</ArticleId><ArticleId IdType="pmc">PMC6161739</ArticleId><ArticleId IdType="pubmed">30288079</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Ye B, Han J, Kong F, Shan P, Lu Z, et al. Nacht, Lrr and Pyd domains-containing protein 3 inflammasome is activated and inhibited by berberine via toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-kappab pathway, in phorbol 12-myristate 13-acetate-induced macrophages. Mol Med Rep. (2018) 17:2673&#x2013;80. 10.3892/mmr.2017.8189</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.8189</ArticleId><ArticleId IdType="pubmed">29207123</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich P, Behrmann I, Haan S, Hermanns H, Muller-Newen G, Schaper F. Principles of interleukin (Il)-6-type cytokine signalling and its regulation. Biochem J. (2003) 374(Pt. 1):1&#x2013;20. 10.1042/BJ20030407</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20030407</ArticleId><ArticleId IdType="pmc">PMC1223585</ArticleId><ArticleId IdType="pubmed">12773095</ArticleId></ArticleIdList></Reference><Reference><Citation>Low Z, Zabidi N, Yip A, Puniyamurti A, Chow V, Lal S. Sars-Cov-2 non-structural proteins and their roles in host immune evasion. Viruses. (2022) 14:1991. 10.3390/v14091991</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091991</ArticleId><ArticleId IdType="pmc">PMC9506350</ArticleId><ArticleId IdType="pubmed">36146796</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris R, Kershaw N, Babon J. The molecular details of cytokine signaling via the Jak/Stat pathway. Protein Sci. (2018) 27:1984&#x2013;2009. 10.1002/pro.3519</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3519</ArticleId><ArticleId IdType="pmc">PMC6237706</ArticleId><ArticleId IdType="pubmed">30267440</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, Kubli S, Yoshinaga S, Pfeffer K, Mak T. An aberrant stat pathway is central to COVID-19. Cell Death Differ. (2020) 27:3209&#x2013;25. 10.1038/s41418-020-00633-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00633-7</ArticleId><ArticleId IdType="pmc">PMC7545020</ArticleId><ArticleId IdType="pubmed">33037393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandhaya-Pillai R, Miro-Mur F, Alijotas-Reig J, Tchkonia T, Kirkland J, Schwartz S. Tnfalpha-senescence initiates a stat-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion. Aging. (2017) 9:2411&#x2013;35. 10.18632/aging.101328</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101328</ArticleId><ArticleId IdType="pmc">PMC5723694</ArticleId><ArticleId IdType="pubmed">29176033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Li Z, Liu X, Peng Q, Li F, Li D, et al. Effect of liuweibuqi capsule, a chinese patent medicine, on the Jak1/Stat3 pathway and Mmp9/Timp1 in a chronic obstructive pulmonary disease rat model. J Tradit Chin Med. (2015) 35:54&#x2013;62. 10.1016/s0254-6272(15)30009-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0254-6272(15)30009-1</ArticleId><ArticleId IdType="pubmed">25842729</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Wang Z, Zhang J, Wang Y, Yu C, Zhang J, et al. Feifukang ameliorates pulmonary fibrosis by inhibiting Jak-Stat signaling pathway. BMC Complement Altern Med. (2018) 18:234. 10.1186/s12906-018-2297-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-018-2297-3</ArticleId><ArticleId IdType="pmc">PMC6085667</ArticleId><ArticleId IdType="pubmed">30092799</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Zhang W. Zhuye shigao decoction combined with qingqi huatan pills in alleviating the acute exacerbation of chronic obstructive pulmonary disease (phlegm-heat stagnating in the lungs) via the il-6-mediated Jak1/Stat3 signaling pathway. Evid Based Complement Alternat Med. (2022) 2022:7942623. 10.1155/2022/7942623</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7942623</ArticleId><ArticleId IdType="pmc">PMC9106455</ArticleId><ArticleId IdType="pubmed">35571736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, et al. The roles of eph receptors, neuropilin-1, p2x7, and cd147 in COVID-19-associated neurodegenerative diseases: inflammasome and Jak inhibitors as potential promising therapies. Cell Mol Biol Lett. (2022) 27:10. 10.1186/s11658-022-00311-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-022-00311-1</ArticleId><ArticleId IdType="pmc">PMC8809072</ArticleId><ArticleId IdType="pubmed">35109786</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Xu X, Hu J, Chen Q, Xu F, Liang H, et al. Clinical course and risk factors for recurrence of positive sars-cov-2 rna: a retrospective cohort study from Wuhan, China. Aging. (2020) 12:16675&#x2013;89. 10.18632/aging.103795</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103795</ArticleId><ArticleId IdType="pmc">PMC7521537</ArticleId><ArticleId IdType="pubmed">32909961</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Sun Y. The Il-6/Jak/Stat3 pathway: potential therapeutic strategies in treating colorectal cancer (review). Int J Oncol. (2014) 44:1032&#x2013;40. 10.3892/ijo.2014.2259</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2014.2259</ArticleId><ArticleId IdType="pubmed">24430672</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant A, Estrada A, III, Ayala-Marin Y, Alvidrez-Camacho A, Rodriguez G, Robles-Escajeda E, et al. The many faces of jaks and stats within the COVID-19 storm. Front Immunol. (2021) 12:690477. 10.3389/fimmu.2021.690477</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.690477</ArticleId><ArticleId IdType="pmc">PMC8313986</ArticleId><ArticleId IdType="pubmed">34326843</ArticleId></ArticleIdList></Reference><Reference><Citation>Seif F, Aazami H, Khoshmirsafa M, Kamali M, Mohsenzadegan M, Pornour M, et al. Jak inhibition as a new treatment strategy for patients with COVID-19. Int Arch Allergy Immunol. (2020) 181:467&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270061</ArticleId><ArticleId IdType="pubmed">32392562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandhaya-Pillai R, Yang X, Tchkonia T, Martin G, Kirkland J, Oshima J. Tnf-Alpha/Ifn-gamma synergy amplifies senescence-associated inflammation and sars-cov-2 receptor expression via hyper-activated Jak/Stat1. Aging Cell. (2022) 21:e13646. 10.1111/acel.13646</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13646</ArticleId><ArticleId IdType="pmc">PMC9197409</ArticleId><ArticleId IdType="pubmed">35645319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wu C. In Silico, in vitro, and in vivo evaluation of the developmental toxicity, estrogenic activity, and mutagenicity of four natural phenolic flavonoids at low exposure levels. ACS Omega. (2022) 7:4757&#x2013;68. 10.1021/acsomega.1c04239</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.1c04239</ArticleId><ArticleId IdType="pmc">PMC8851455</ArticleId><ArticleId IdType="pubmed">35187296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ode O, Asuzu I. Luteolin isolate from the methanol extract identified as the single-carbon compound responsible for broad antiulcer activities of cassia singueana leaves. IOSR J Pharm. (2014) 4:17&#x2013;23.</Citation></Reference><Reference><Citation>Kanai K, Nagata S, Hatta T, Sugiura Y, Sato K, Yamashita Y, et al. Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in lewis rats. J Vet Med Sci. (2016) 78:1381&#x2013;4. 10.1292/jvms.16-0196</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.16-0196</ArticleId><ArticleId IdType="pmc">PMC5053947</ArticleId><ArticleId IdType="pubmed">27170432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>